Biodesix, Inc. (BDSX)
NASDAQ: BDSX · Real-Time Price · USD
0.3973
+0.0138 (3.60%)
Aug 14, 2025, 1:45 PM - Market open
Biodesix Market Cap
Biodesix has a market cap or net worth of $58.26 million as of August 14, 2025. Its market cap has decreased by -76.52% in one year.
Market Cap
58.26M
Enterprise Value
107.98M
1-Year Change
-76.52%
Ranking
Category
Stock Price
$0.40
Market Cap Chart
Since October 28, 2020, Biodesix's market cap has decreased from $336.31M to $58.26M, a decrease of -82.68%. That is a compound annual growth rate of -30.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 56.23M | -74.73% |
| Dec 31, 2024 | 222.56M | 33.69% |
| Dec 29, 2023 | 166.48M | -5.38% |
| Dec 30, 2022 | 175.94M | 23.06% |
| Dec 31, 2021 | 142.97M | -73.28% |
| Dec 31, 2020 | 535.07M | 59.10% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 574.04B |
| Johnson & Johnson | 416.11B |
| AbbVie | 350.91B |
| UnitedHealth Group | 236.90B |
| AstraZeneca | 232.33B |
| Novartis AG | 230.64B |
| Abbott Laboratories | 228.03B |
| Novo Nordisk | 223.00B |